Clinical Trials, Industry, Research and Development, Vaccines
December 14, 2022
Via: PharmaphorumThe two partners have revealed the first clinical data from a phase 2b trial of a personalised vaccine consisting of 34 mRNAs, each targeting mutations – identified by gene sequencing – that are thought to be driving a patient’s cancer. […]